-
Citi Puts Out New Positive Catalyst Watch on Four Names (earlier)
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals (APLS) PT Raised to $67 at Citi on Sobi Deal
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals (APLS) Prices 9.5M Share Offering at $37/Sh
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) Announces Proposed 7M Share Common Offering
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) PT Raised to $80 at Citi
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Apellis Pharmaceuticals (APLS) PT Lowered to $37 at Citi
-
Apellis Pharmaceuticals (APLS) PT Lowered to $38 at Citi
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals (APLS) Prices 6M Share Common Offering at $17/Sh
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) to Offer $75M in Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) PT Raised to $40 at Citi
-
Apellis Pharmaceuticals (APLS) PT Raised to $40 at Citi
-
Apellis Pharmaceuticals (APLS) PT Raised to $34 at Citi
-
Apellis Pharmaceuticals Announces Closing of Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) Prices 5.5M Share Offering at $25.50/Sh
-
Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock
-
Apellis Pharmaceuticals Announces Proposed Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) PT Raised to $30 at Citi
-
Citi Starts Apellis Pharmaceuticals (APLS) at Buy
-
Apellis Pharmaceuticals Announces Closing of its Initial Public Offering
-
Apellis Pharmaceuticals (APLS) Prices 10.7M Share IPO at $14/Sh
-
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering